Lixte Biotechnology Holdings, Inc. Stock
Equities
LIXT
US5393193017
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.465 USD | +3.40% | -0.43% | +47.45% |
Mar. 27 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
Mar. 27 | Top Midday Gainers | MT |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 5.29M |
---|---|---|---|---|---|
Net income 2022 | -6M | Net income 2023 | -5M | EV / Sales 2022 | - |
Net cash position 2022 | 5.35M | Net cash position 2023 | 4.2M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.28
x | P/E ratio 2023 |
-0.88
x | Employees | 4 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 68.81% |
1 day | +3.40% | ||
1 week | -0.43% | ||
Current month | +2.51% | ||
1 month | +50.65% | ||
3 months | +61.16% | ||
6 months | +40.85% | ||
Current year | +47.45% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 22-06-16 | |
Director of Finance/CFO | 72 | 20-08-11 | |
Eric Forman
COO | Chief Operating Officer | 44 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
René Bernards
BRD | Director/Board Member | 72 | 22-06-14 |
Chief Executive Officer | 52 | 22-06-16 | |
Yun Yen
BRD | Director/Board Member | 70 | 18-08-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 3.465 | +3.40% | 11,174 |
24-04-18 | 3.351 | +0.63% | 18,311 |
24-04-17 | 3.33 | -4.86% | 12,501 |
24-04-16 | 3.5 | +6.06% | 22,066 |
24-04-15 | 3.3 | -5.17% | 18,906 |
Delayed Quote Nasdaq, April 19, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+47.45% | 7.54M | |
-1.42% | 41.35B | |
+42.15% | 40.38B | |
+1.97% | 39.05B | |
-14.19% | 26.67B | |
+1.82% | 24.07B | |
-24.55% | 18.36B | |
-4.07% | 11.68B | |
+21.36% | 11.6B | |
+8.20% | 11.15B |
- Stock Market
- Equities
- LIXT Stock